The Legal Intelligencer | Analysis
By Aleeza Furman | August 4, 2022
Trial attorney Thomas Kline said litigation over the weed-killer Roundup is "going to be the marquee in the program for the foreseeable future."
By Amanda Bronstad | August 3, 2022
The trial, in Missouri, is the first since Bayer, which owns Monsanto, lost three potential appeals about Roundup, including two before the U.S. Supreme Court.
By Cedra Mayfield | August 3, 2022
"Our goal is to break the mold of the current mass litigation leadership model to remedy the lack of diversity and allow attorneys of color to uplift and defend their own communities," said Shades of Mass founder Ben Crump.
The Legal Intelligencer | News
By Aleeza Furman | August 1, 2022
In the time since the start of the litigation, many defendants settled, and three remaining defendants went on to trial against a group of grocery store chains designated as direct action plaintiffs.
By Ellen Bardash | August 1, 2022
Attorneys for some of the 82,209 total abuse claimants said Monday they're looking to make adjustments and get a final confirmation order in place within a month.
By Amanda Bronstad | August 1, 2022
New Jersey Chief Bankruptcy Judge Michael Kaplan said Ken Feinberg's role in the Chapter 11 case of Johnson & Johnson's LTL Management would be as a "court-appointed estimation expert," who would prepare a report on the value and volume of current and future claims alleging talcum powder caused ovarian cancer or mesothelioma.
By Amanda Bronstad | July 29, 2022
Allergan's $2.37 billion settlement, reached with a bipartisan group of state attorneys general to resolve lawsuits over the opioid crisis, comes five days after another drug manufacturer, Teva, reached a $4.25 billion deal.
By Amanda Bronstad | July 29, 2022
The deal, announced by attorneys general in eight states, including California and Illinois, comes five days after another opioid manufacturer, Teva Pharmaceutical Industries Ltd., reached a $4.25 billion deal to resolve thousands of lawsuits.
By Amanda Bronstad | July 29, 2022
Chief Bankruptcy Judge Michael Kaplan announced the decision on Thursday after ruling in favor of Johnson & Johnson subsidiary LTL Management on how to proceed with its Chapter 11 bankruptcy, which aims to resolve at least 38,000 lawsuits filed by ovarian cancer and mesothelioma victims.
By Amanda Bronstad | July 28, 2022
Chief Bankruptcy Judge Michael Kaplan announced the decision on Thursday after ruling in favor of Johnson & Johnson subsidiary LTL Management on how to proceed with its Chapter 11 bankruptcy, which aims to resolve at least 38,000 lawsuits filed by ovarian cancer and mesothelioma victims.
Presented by BigVoodoo
This conference aims to help insurers and litigators better manage complex claims and litigation.
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
Legalweek New York explores Business and Regulatory Trends, Technology and Talent drivers impacting law firms.
McCarter & English, LLP, a well established and growing law firm, is actively seeking a talented and driven associate having 2-5 years o...
Gill & Chamas, LLC seeks a Personal Injury attorney to work in their Woodbridge, NJ office. Candidate must possess the following: ...
We are seeking an attorney with a minimum of four years of experience in transactional work to join our well-established, nationally renowne...